-
German Researchers Identify New Biomarker for Malignant Mesothelioma
Medical researchers are relentlessly searching for answers to the puzzle of malignant mesothelioma, the rare and deadly asbestos-related disease that has proven so resistant to traditional cancer treatments. A recent discovery by researchers in Germany has provided an important piece of the puzzle: The scientists have identified a biomarker that is both more accurate than
-
Study Suggests Blood Fluid Ratio as Accurate Predictor of Mesothelioma Prognosis
Though malignant pleural mesothelioma is always considered fatal, some patients fare better with the disease than others, and have longer survival times. A recent study authored by Greek researchers suggests that an easy-to-perform blood analysis can provide a highly accurate prognosis for patients diagnosed with malignant pleural mesothelioma.
-
88-Year-Old Asbestos Lung Cancer Victim Prevails Against Three Asbestos Companies
Three years ago, 85-year-old Josip L Radovic was diagnosed with asbestos-related lung cancer, a disease that, like malignant mesothelioma, is frequently caused by workplace exposure to the toxic mineral. He filed a lawsuit naming multiple companies whose products he had worked with decades earlier, and several of them filed motions to have the case against
-
Lung Cancer Victims Permitted to Join Claims Against Asbestos Company
Asbestos-related lung cancer and malignant mesothelioma are both aggressive and deadly outcomes of asbestos exposure. The vast majority of those diagnosed with these diseases trace their exposure to their careers, and many take legal action against product manufacturers and others who were negligent in failing to warn or protect them. When victims find they were exposed
-
Mesothelioma Widow is Victorious in Claim Against Late Husband’s Employer
Though most mesothelioma claims involve seeking compensation from product manufacturers, many people affected by the disease also seek benefits offered by their employers’ workers’ compensation policy. When Karen Reid’s husband died of the rare, asbestos-related disease in 2019, she filed a claim with the company he’d retired from in 1990 but ended up in a
-
Valve Manufacturer’s Expert Witness Fails in Attempt to Have Mesothelioma Claim Dismissed
Willie Hollingsworth died of malignant mesothelioma after having been exposed to asbestos in a variety of products and work environments. His survivors filed a personal injury lawsuit against those they blamed for his illness and death, including McWane, Inc. on behalf of its unincorporated division Clow Valve Company. Though the company attempted to have the
-
Mesothelioma Victim Points to Asbestos in DAP Products as Cause of Illness
Before Jose Munoz died of malignant mesothelioma, he testified against the companies he blamed for having exposed him to asbestos. He recalled working with DAP, Inc. caulks and plaster products, and the dust he’d inhaled when sanding those products down. Though DAP asserted that the case against them should be dismissed, arguing that their products
-
Efficacy of Immunotherapy May Be Offset by Adverse Events in Mesothelioma Patients
A just-released study conducted in the Netherlands provides a mixed assessment of the use of nivolumab-ipilimumab immunotherapy in patients with malignant pleural mesothelioma. While researchers found that the real-world efficacy of the combination was comparable to what was reported in a phase 3 study, they also reported that toxicities – particularly among elderly patients –
-
Carnival Cruise Worker’s Family Seeks Justice Following Mesothelioma Death
Basilio Gallo died of malignant mesothelioma after decades of working on board Carnival Corporation’s popular cruise vessels, and his widow and daughter are seeking justice against the company and 30 others that they say exposed him to asbestos. Their wrongful death lawsuit has seen many twists and turns, but this week a Florida federal judge
-
Viennese Researchers Identify New Therapeutic Target for Mesothelioma
A group of researchers from cancer centers in Vienna has announced that they’ve identified a therapeutic target that, when inhibited, enhances mesothelioma tumors’ sensitivity to chemotherapy and radiotherapy. The group believes that this approach may yield a novel and effective treatment approach for the rare, asbestos-related disease.
-
Pump Manufacturer Points to 85-Year-Old’s Memory Lapse to Evade Asbestos Liability
One of the most challenging aspects of pursuing a mesothelioma or asbestos-related lung cancer lawsuit is the significant gap between when the victim’s exposure took place and when their illness is diagnosed. It’s hard for anybody to remember details from four or five decades earlier, and this is especially true when fighting a fatal disease.
-
Asbestos in Air Compressor Gaskets Blamed for Man’s Lung Cancer
After he was diagnosed with asbestos-related lung cancer, Kenneth Nankevis filed suit against multiple companies whose contaminated products he had worked with during his career. His suit accused the companies of negligently exposing him to the carcinogenic material and causing his illness. Though air compressor company Campbell Hausfeld, LLC filed a petition to have the
-
Airplane Parts Maker Must Face Claims from Asbestos Lung Cancer Victim’s Family
82-year-old Gustave Sahm died of asbestos-related lung cancer in 2021. His heartbroken family filed suit against over a dozen companies that they accused of negligence in exposing him to the toxic substance. A U.S. District judge recently ruled that their claims against airplane parts maker Morton International can move forward for a jury to decide.
-
Montana Talc Supplier Facing Mesothelioma Claims is Challenged on Bankruptcy Filing
A talc supplier facing hundreds of asbestos-related claims from mesothelioma victims and others is facing legal pushback in response to its attempt to file for bankruptcy in Texas. Barretts Minerals is based in Montana and has been accused by challengers of “blatant forum shopping” by creditors who are trying to move the filing back to
-
Montana Woman Files Mesothelioma Claim Against BNSF Railway
Libby, Montana resident Karen Morey was diagnosed with malignant pleural mesothelioma in November of 2022. Knowing the history of her town and the constant exposure to asbestos that residents like herself suffered as a result of its proximity to the W.R. Grace & Co. vermiculite mine, she filed a lawsuit against BNSF Railway, seeking compensation
-
Johnson & Johnson Settles More Talcum Powder Mesothelioma Cases
Following a second denial of its bankruptcy application and concerns about future growth, Johnson & Johnson has quietly settled about 100 mesothelioma and ovarian cancer talcum powder lawsuits and is said to be attempting to resolve many more of them. The move is apparently meant to avoid damaging verdicts in the jury trials that are
-
Mesothelioma Concerns Raised Over Russia/Ukraine War Debris
The two-year anniversary of the war in Ukraine is rapidly approaching, and even as the battle continues, health professionals are beginning to express concerns over future mesothelioma risk from the asbestos-contaminated debris left behind by Russian missile strikes. The European Union has recognized the risks involved and is beginning to make plans for protecting citizens
-
Occupational and Non-Occupational Exposure Blamed for Man’s Mesothelioma
Wilburn Freeman died of malignant mesothelioma after years of working with asbestos-containing products, including Georga Pacific’s pre-mixed joint compound. When his family pursued a claim against the company, they filed a motion to have it dismissed, arguing that the product was not on the market in the years cited in the lawsuit. Based on Freeman’s
-
UK Study Suggests that AI Tool Can Help Diagnose Mesothelioma
A new study from researchers at King’s College in London suggests that an Artificial-Intelligence-based tool called MesoGraph will prove valuable in helping diagnose future cases of malignant mesothelioma. The study’s authors indicate that the tool may also help guide clinicians to more effective treatments for individual patients.
-
Mesothelioma Study Reveals Higher Toxicity of Immunotherapy Than Reported from Trial
Despite the best efforts of researchers, malignant pleural mesothelioma remains a terminal diagnosis. What science has been able to offer has been extended survival times, largely through the use of innovative immunotherapy treatments. Though clinical trials of the dual regimen of ipilimumab and nivolumab has promised improved outcomes, a recently published study has shown that
